{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:39Z","timestamp":1761178599509,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.canrad.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:28:15Z","timestamp":1690882095000},"page":"387-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radioth\u00e9rapie st\u00e9r\u00e9otaxique (RTST) pulmonaire des tumeurs de moins de 3 cm (stade I) et 5 cm (stade II) non op\u00e9r\u00e9es\u00a0: 10\u00a0ans d\u2019exp\u00e9rience de l\u2019Institut du Cancer de Montpellier (ICM)"],"prefix":"10.1016","volume":"27","author":[{"given":"A.","family":"Marguerit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Azria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Demontoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Thezenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Boisselier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim Synth\u00e8se","author":"Gautier Defossez","key":"10.1016\/j.canrad.2023.05.002_bib0275"},{"key":"10.1016\/j.canrad.2023.05.002_bib0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.rmr.2018.01.008","article-title":"Smoking and vaping in France","volume":"35","author":"Andler","year":"2018","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.canrad.2023.05.002_bib0285","series-title":"R\u00e9f\u00e9rentiels Auvergne Rh\u00f4ne-Alpes en oncologie thoracique","first-page":"1","author":"Couraud","year":"2019"},{"year":"2020","series-title":"NCCN clinical practice guidelines in oncology - Non small cell lung cancer - v 1. 2020","key":"10.1016\/j.canrad.2023.05.002_bib0290"},{"key":"10.1016\/j.canrad.2023.05.002_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(03)00152-1","article-title":"The role of radiotherapy in treatment of stage I non-small cell lung cancer","volume":"41","author":"Qiao","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2023.05.002_bib0300","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.128.3.1461","article-title":"Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer","volume":"128","author":"Wisnivesky","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.canrad.2023.05.002_bib0305","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1002\/cncr.29640","article-title":"Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis","volume":"121","author":"Nanda","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.05.002_bib0310","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1\u00a0non-small-cell lung cancer (TROG 09.02\u00a0CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0315","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JCO.2009.25.0928","article-title":"Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer","volume":"28","author":"Grills","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0320","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2011.06.2003","article-title":"Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage i non-small cell lung cancer","volume":"83","author":"Lagerwaard","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.05.002_bib0325","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2011.06.029","article-title":"Treatment of stage i NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery","volume":"101","author":"Palma","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0330","first-page":"e53","article-title":"Stereotactic ablative radiotherapy as an alternative to lobectomy in patients with medically operable stage I NSCLC: a retrospective, multicenter analysis","volume":"20","author":"Scotti","year":"2019","journal-title":"Clin Lung Can"},{"key":"10.1016\/j.canrad.2023.05.002_bib0335","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijrobp.2014.05.055","article-title":"Survival outcome after stereotactic body radiation therapy and surgery for stage i non-small cell lung cancer: a meta-analysis","volume":"90","author":"Zheng","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0340","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2018.01.064","article-title":"Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies","volume":"101","author":"Chen","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.05.002_bib0345","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Artic Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0350","doi-asserted-by":"crossref","first-page":"S837","DOI":"10.1016\/j.jtho.2018.08.1491","article-title":"SABRTOOTH: a fasibility study of SABR versus surgery in patients with peripheral stage I NSCLC considered to be at higher risk for surgery","volume":"13","author":"Franks","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0355","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21\u00a0years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0360","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245\u00a0subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.05.002_bib0365","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0375","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report 91\u00a0on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0380","first-page":"1","article-title":"Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer","volume":"94","author":"Chi","year":"2010","journal-title":"Clinical implications"},{"key":"10.1016\/j.canrad.2023.05.002_bib0385","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2018.01.064","article-title":"Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies","volume":"101","author":"Chen","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/thoraxjnl-2018-212493","article-title":"Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England","volume":"75","author":"Khakwani","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.canrad.2023.05.002_bib0395","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10147-019-01432-y","article-title":"Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review","volume":"24","author":"Doi","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0400","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.2217\/fon-2019-0240","article-title":"Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer?. A systematic review and meta-analysis","volume":"15","author":"Luo","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0405","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.prro.2018.09.003","article-title":"Impact of Tumor size on local control and pneumonitis after stereotactic body radiation therapy for lung tumors","volume":"9","author":"Parker","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0410","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: a comparison of T1\u00a0and T2\u00a0peripheral non\u2013small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0415","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1\u00a0non-small-cell lung cancer (TROG 09.02\u00a0CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0420","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.2017.74.9671","article-title":"Stereotactic body radiotherapy for early-stage non\u2013small-cell lung cancer: american society of clinical oncology endorsement of the american society for radiation oncology evidence-based guideline","volume":"36","author":"Schneider","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0425","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Feng","year":"2015","journal-title":"Artic Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0430","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable Stage i non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.05.002_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hyw058","article-title":"Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: Comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)","volume":"46","author":"Eba","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0440","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00595-017-1536-4","article-title":"Surgery or stereotactic body radiotherapy for elderly stage I lung cancer?. A propensity score matching analysis","volume":"47","author":"Miyazaki","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.canrad.2023.05.002_bib0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13014-020-1479-6","article-title":"Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy","volume":"15","author":"Ryckman","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0450","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/tlcr.2018.10.06","article-title":"The evolving toxicity profile of SBRT for lung cancer","volume":"8","author":"Thompson","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.canrad.2023.05.002_bib0455","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1754-9485.12583","article-title":"Efficacy of flattening-filter-free beam in stereotactic body radiation therapy planning and treatment: a systematic review with meta-analysis","volume":"61","author":"Dang","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13019-018-0773-y","article-title":"Radiofrequency ablation of stage IA non\u2013small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial","volume":"13","author":"Palussi\u00e8re","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0465","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.2431060088","article-title":"Pulmonary radiofrequency ablation: long-term safety and efficacy in 153\u00a0patients","volume":"243","author":"Simon","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2023.05.002_bib0470","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtcvs.2008.08.034","article-title":"Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer","volume":"137","author":"Lanuti","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0475","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jtcvs.2007.07.013","article-title":"Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20\u00a0nonsurgical candidates","volume":"134","author":"Hiraki","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0480","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jtcvs.2007.04.060","article-title":"Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients","volume":"134","author":"Pennathur","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0485","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/JTO.0b013e31822d538d","article-title":"Long-term results of radiofrequency ablation treatment of stage i non-small cell lung cancer: A prospective intention-to-treat study","volume":"6","author":"Ambrogi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0490","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jtcvs.2004.10.019","article-title":"Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates","volume":"129","author":"Fernando","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0495","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jso.23701","article-title":"Percutaneous microwave ablation of stage i medically inoperable non-small cell lung cancer: Clinical evaluation of 47\u00a0cases","volume":"110","author":"Yang","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0500","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jvir.2014.12.006","article-title":"Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients","volume":"26","author":"Moore","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jamcollsurg.2010.03.020","article-title":"Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer","volume":"211","author":"Zemlyak","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.canrad.2023.05.002_bib0510","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0515","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: a paradigm shift","volume":"105","author":"Formenti","year":"2013","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2023.05.002_bib0520","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation therapy to convert the tumor into an in situ vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0525","first-page":"1","article-title":"Lung stereotactic body radiation therapy and concurrent immunotherapy: a multicenter safety and toxicity analysis","volume":"36","author":"Tian","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0530","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage iii non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.05.002_bib0535","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13014-019-1314-0","article-title":"Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR","volume":"14","author":"Park","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.05.002_bib0270","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2020.02.025","article-title":"Clinical outcomes of stereotactic mr-guided adaptive radiation therapy for high-risk lung tumors","volume":"107","author":"Finazzi","year":"2020","journal-title":"Int J Radiat Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182300118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182300118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:37:52Z","timestamp":1761136672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182300118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S127832182300118X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.05.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique (RTST) pulmonaire des tumeurs de moins de 3cm (stade I) et 5cm (stade II) non op\u00e9r\u00e9es\u00a0: 10\u00a0ans d\u2019exp\u00e9rience de l\u2019Institut du Cancer de Montpellier (ICM)","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}